Johnson & Johnson Gets FDA Fast-Track Designation for Posdinemab in Alzheimer's
The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
Johnson & Johnson Drug Combination Shows Positive Results in Lung Cancer Study
Johnson & Johnson said it received positive topline results in a Phase 3 study of a combination of drugs to treat patients with locally advanced or metastatic non-small cell lung cancer.
Three Republicans jeopardized Johnson's re-election as speaker; two changed minds
Three Republican holdouts appeared to block the re-election U.S. House Speaker Mike Johnson, R-La., during the first round of ...
Johnson wins dramatic reelection as speaker after 2 GOP hard-liners switch votes
The House of Representatives on Friday is voting on electing a speaker for the new Congress. Mike Johnson, a Louisiana ...